Essex Investment Management’s Myriad Genetics MYGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-116,709	Closed	-$1.6M	–	318
2024 Q4	$1.6M	Sell	116,709 -119,132	-51%	-$1.63M	0.29%	130
2024 Q3	$6.46M	Sell	235,841 -4,287	-2%	-$117K	1.13%	17
2024 Q2	$5.87M	Buy	+240,128	New	+$5.87M	1.1%	21